The Green Firm has been retained to investigate the more than $500,000 in losses suffered by a professional investor based in Pennsylvania who was unable to sell shares of Provectus Biopharmaceutical stock (PVCT) on January 23, 2104. This investor was prevented from selling PVCT for most of the trading day by his long-time brokerage firm, TD Ameritrade, during a day of extraordinary trading activity (more than 30 million shares) and the stock's crash from above $6 per share to below $2 per share.